Neurobiology of pain.

The neurobiology of pain has had extensive research directed at identifying the mechanisms of nociceptive transmission and integration. Clinical conditions of chronic pain including phantom limb pain cannot be explained without an understanding of the complex mechanisms of pain regulation. An overview of the neurobiological organization of the nociceptive system, from different pain fiber types to subcortical and cortical experiential centers, is presented, along with a brief description of the known cross talk within the system and between pain pathways and those for other information. Finally, interactions between affective, executive, and cognitive processes and pain experiences are described briefly.

[1]  G. Neeck,et al.  Nociception, pain, and antinociception: current concepts , 2001, Zeitschrift für Rheumatologie.

[2]  G. Bennett.  Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. , 2000, Journal of pain and symptom management.

[3]  M. Fundytus.  Glutamate Receptors and Nociception , 2001, CNS drugs.

[4]  R. Helme,et al.  Sensory peptides as neuromodulators of wound healing in aged rats. , 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.

[5]  M. Zimmermann,et al.  Pathobiology of neuropathic pain. , 2001, European journal of pharmacology.

[6]  Allan I. Basbaum,et al.  Central nervous system mechanisms of pain modulation , 2006 .

[7]  A. Dickenson,et al.  Neurobiology of neuropathic pain: mode of action of anticonvulsants , 2002, European journal of pain.

[8]  P. Cabot,et al.  Opioids and inflammation , 1997 .

[9]  S. Harkins,et al.  Suppression of first pain and slow temporal summation of second pain in relation to age. , 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  R. Helme,et al.  The effect of age on Aδ- and C-fibre thermal pain perception , 1996, Pain.

[11]  R. Helme,et al.  Effects of ageing on sensory nerve function in rat skin , 1994, Brain Research.

[12]  G. Baranauskas,et al.  SENSITIZATION OF PAIN PATHWAYS IN THE SPINAL CORD: CELLULAR MECHANISMS , 1998, Progress in Neurobiology.

[13]  P. Césaro,et al.  Pain and its treatments. , 1997, European neurology.

[14]  J. Pin,et al.  The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. , 2002, Current drug targets. CNS and neurological disorders.

[15]  B. Cooper,et al.  Aging effects on the perception of noxious and non-noxious thermal stimuli applied to the face , 1996, Aging.

[16]  R. Helme,et al.  Age-related changes in sympathetic modulation of sensory nerve activity in rat skin , 1998, Inflammation Research.

[17]  R. Helme,et al.  Effects of age on the axon reflex response to noxious chemical stimulation. , 1986, Clinical and experimental neurology.

[18]  G. Gebhart,et al.  Chronic pain and medullary descending facilitation , 2002, Trends in Neurosciences.

[19]  S. McMahon,et al.  The changing role of primary afferent neurones in pain , 1990, Pain.

[20]  W. Willis,et al.  Sensory Mechanisms of the Spinal Cord , 1991, Springer US.

[21]  A. Lipman.  Analgesic drugs for neuropathic and sympathetically maintained pain. , 1996, Clinics in geriatric medicine.

[22]  C. Parsons,et al.  NMDA receptors as targets for drug action in neuropathic pain. , 2001, European journal of pharmacology.

[23]  William R Lariviere,et al.  The role of corticotropin-releasing factor in pain and analgesia , 2000, Pain.

[24]  C. Woolf,et al.  The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord. , 1994, Journal of neurophysiology.

[25]  D. Price.  Psychological and neural mechanisms of the affective dimension of pain. , 2000, Science.

[26]  N. Lane,et al.  Pain management in osteoarthritis: the role of COX-2 inhibitors. , 1997, The Journal of rheumatology. Supplement.

[27]  P. Wall,et al.  Pain mechanisms: a new theory. , 1965, Science.

[28]  D. Lima,et al.  The medullary dorsal reticular nucleus as a pronociceptive centre of the pain control system , 2002, Progress in Neurobiology.

[29]  Alan C. Evans,et al.  Multiple representations of pain in human cerebral cortex. , 1991, Science.

[30]  C. Woolf,et al.  Preemptive analgesia--treating postoperative pain by preventing the establishment of central sensitization. , 1993 .

[31]  Kjell Någren,et al.  Striatal dopamine D1 and D2 receptors in burning mouth syndrome , 2003, Pain.

[32]  Clifford J. Woolf,et al.  The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states , 1991, Pain.

[33]  E. Chudler,et al.  The role of the basal ganglia in nociception and pain , 1995, Pain.

[34]  R. Dworkin.  An Overview of Neuropathic Pain: Syndromes, Symptoms, Signs, and Several Mechanisms , 2002, The Clinical journal of pain.

[35]  M. Moskowitz,et al.  Mechanisms of pain modulation in chronic syndromes , 2002, Neurology.

[36]  C. Goicoechea,et al.  Age-related changes in nociception, behavior, and monoamine levels in rats. , 1997, General pharmacology.

[37]  Igor D. Grachev,et al.  Decreased Levels of N-Acetylaspartate in Dorsolateral Prefrontal Cortex in a Case of Intractable Severe Sympathetically Mediated Chronic Pain (Complex Regional Pain Syndrome, Type I) , 2002, Brain and Cognition.

[38]  P. Siddall,et al.  BRIEF REVIEW PAIN MECHANISMS AND MANAGEMENT: AN UPDATE , 1995 .

[39]  M. Millan.  Descending control of pain , 2002, Progress in Neurobiology.

[40]  A. Mendonça,et al.  Adenosine receptors in the nervous system: pathophysiological implications , 2002, Progress in Neurobiology.

[41]  J. Mao,et al.  Altered Expression and Uptake Activity of Spinal Glutamate Transporters after Nerve Injury Contribute to the Pathogenesis of Neuropathic Pain in Rats , 2003, The Journal of Neuroscience.

[42]  A I Basbaum,et al.  Peptides and the primary afferent nociceptor , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  Karl J. Friston,et al.  Cortical and subcortical localization of response to pain in man using positron emission tomography , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[44]  Karen Faith Berman,et al.  Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain , 1995, Pain.

[45]  T. Meert,et al.  Potentiation of the Analgesic Properties of Fentanyl-like Opioids with α2-Adrenoceptor Agonists in Rats , 1994, Anesthesiology.

[46]  A. Basbaum.  Mechanisms of Substance P-Mediated Nociception and Opioid-Mediated Antinociception , 1994 .

[47]  G. Di Chiara,et al.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[48]  D. Castell,et al.  Evidence for diminished visceral pain with aging: studies using graded intraesophageal balloon distension. , 1997, American Journal of Physiology.

[49]  Stephen P. Hunt,et al.  The molecular dynamics of pain control , 2001, Nature Reviews Neuroscience.

[50]  D. Trist,et al.  Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications. , 2000, Pharmaceutica acta Helvetiae.

[51]  W. Slikker,et al.  Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.